Development of a Fetal Sex Assay From Maternal Whole Blood
NCT00970047 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 500
Last updated 2011-02-02
Summary
Whole blood from pregnant women will be collected to develop a noninvasive fetal sex test.
Conditions
- Fetal Sex Determination
Sponsors & Collaborators
-
Sequenom, Inc.
lead INDUSTRY
Principal Investigators
-
Allan Bombard, MD, MBA · Sequenom, Inc.
Eligibility
- Min Age
- 18 Years
- Max Age
- 64 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-06-30
- Primary Completion
- 2010-07-31
- Completion
- 2010-07-31
Countries
- United States
Study Locations
More Related Trials
-
Development of a Prenatal Test for Fetal Aneuploidy Detection
NCT01451671 ·Status: COMPLETED
-
Specimen Collection from Pregnant Women At Increased Risk for Fetal Aneuploidy
NCT01429389 ·Status: RECRUITING
-
Development of Non-invasive Prenatal Test for Microdeletion and Other Genetic Syndromes Based on Cell Free DNA
NCT02109770 ·Status: COMPLETED
-
Non-invasive Prenatal Diagnostic Validation Study
NCT01574781 ·Status: COMPLETED
-
Multiple Gestation Study
NCT02278536 ·Status: COMPLETED
-
Development of New Prenatal Diagnostic Tests From Maternal Blood
NCT00314691 ·Status: TERMINATED ·Phase: NA
-
Collection of Whole Blood Specimens in Pregnant Women
NCT03590678 ·Status: COMPLETED
-
Evaluation of a Noninvasive Fetal RHD Genotyping Test
NCT01054716 ·Status: COMPLETED
-
A Study Collecting Blood Samples From Pregnant Women to Aid in the Development of a Noninvasive Prenatal Test
NCT03620110 ·Status: COMPLETED
-
Non-Invasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
NCT00770458 ·Status: COMPLETED
-
Noninvasive Screening for Affected Pregnancies: Assay Development & Optimization in Affected Pregnancies
NCT01052688 ·Status: COMPLETED
-
Development of an Optimal Approach to Return of Results for Next-generation Sequencing for Prenatal Diagnosis
NCT02255825 ·Status: WITHDRAWN ·Phase: NA
-
A New Prenatal Blood Test for Down Syndrome
NCT00877292 ·Status: COMPLETED
-
Development of a NIPTT for Detecting Copy Number Variations
NCT04774640 ·Status: TERMINATED
-
Technology Development for Noninvasive Prenatal Genetic Diagnosis Using Whole Fetal Cells From Maternal Peripheral Blood
NCT04285814 ·Status: COMPLETED
-
Non-Invasive Screening for Fetal Aneuploidy
NCT00847990 ·Status: COMPLETED
-
A Safer Pre-Natal Diagnosis Using Free DNA in Maternal Blood
NCT01472523 ·Status: COMPLETED
-
Fetal Cell Analysis From Maternal Blood
NCT05671744 ·Status: UNKNOWN ·Phase: NA
-
Clinical Performance of the MaterniT21 PLUS LDT in Multiple Gestation Pregnancies
NCT02226315 ·Status: TERMINATED
-
Prenatal Test for Fetal Aneuploidy Detection
NCT01256606 ·Status: COMPLETED
-
Non Invasive Prenatal Testing (NIPT) of Single-gene Disorders
NCT02339402 ·Status: UNKNOWN
-
Development of a Non-invasive Prenatal Test
NCT01451684 ·Status: COMPLETED
-
Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
NCT00971334 ·Status: COMPLETED
-
Maternal Smoking During Pregnancy and Female Fetal Testosterone Levels
NCT02610751 ·Status: COMPLETED
-
Noninvasive Prenatal Diagnosis: Using Fetal Cells From Maternal Blood
NCT00064597 ·Status: UNKNOWN